Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

With U.S. diagnoses of Parkinson's expected to reach 1.2 million by 2030, research is in full swing, and treatments ...

The common myths about Parkinson’s disease and treatments - People have lots of misconceptions about Parkinson’s disease and ...

"Furthermore, patients with RLS who were not treated with dopamine agonists tended to be at increased risk of developing ...

Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

Parkinson’s breakthrough could unlock treatments for devastating disease - Scientists have developed a groundbreaking new ...

Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.

Researchers have designed a peptide that stabilizes a key brain protein linked to Parkinson’s. Scientists from the University of Bath, working with colleagues at the Universities of Oxford and Bristol ...

"As Parkinson’s disease becomes more common and patients live longer, researchers are stepping up efforts to find better treatments, with nearly half of current studies focused on therapies that could ...